NR3C1 and psoriasis: Ultimately, KC activity in psoriasis is governed by stimulation of key membrane receptors, such as the glucocorticoid receptor (GR) [21], G-protein coupled purinergic receptor P2Y (P2RY11) [22] and epidermal growth factor receptor (EGFR) [23].